- Home
- » Tags
- » Antimetabolite
Top View
- 21462 Pemetrexed Clinpharm BPCA
- Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics in Vitro and in Vivo, Independent of P53 Functionality
- Classification of Antineoplastic Agents by Their Selective Toxicities Toward Oxygenated and Hypoxie Tumor Cells1
- Pharmacogenetics of Pemetrexed Combination Therapy in Lung Cancer: Pathway Analysis Reveals Novel Toxicity Associations
- Floxuridine for Injection, USP for INTRA-ARTERIAL INFUSION ONLY
- DRUG NAME: Methotrexate
- (12) Patent Application Publication (10) Pub. No.: US 2011/0160159 A1 Ryan (43) Pub
- Anti-Cancer Drugs
- Improvement of Purine and Pyrimidine Antimetabolite-Based Anticancer
- Anti-Cancer Compounds / Antineoplastic Agents, Chapter 38
- Antimetabolite L-Canavamne1
- Bendamustine (Treanda) Displays a Distinct Pattern of Cytotoxicity and Unique Mechanistic Features Compared with Other Alkylating Agents Lorenzo M
- Methotrexate Class:Antimetabolite (Antifolate) Indications : Acute
- Antifolate Pseudo-Resistance Due to Elevated Levels of Thymidine and Hypoxanthine in a Commercial Serum Preparation
- Floxuridine | Medchemexpress
- Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
- Bendamustine
- Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art
- Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: from Dose Puzzle to Pharmacogenomic Biomarkers
- Rapamycin Downregulates Thymidylate Synthase and Potentiates the Activity of Pemetrexed in Non-Small Cell Lung Cancer
- Pyrimidine-Based Antifolate That Inhibits Multiple Folate-Requiring Enzymes
- Regulatory News
- DRUG NAME: Gemcitabine
- Inhibition of the Mechanistic Target of Rapamycin Induces Cell Survival Via MAPK in Tuberous Sclerosis Complex Yiyang Lu1, Erik Y
- Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
- Drug Eruptions Associated with Tumor Therapy: Great Imitators
- DNA Alkylator/Crosslinker
- CYTARABINE: Class: Antineoplastic Agent, Antimetabolite (Pyrimidine
- Proteinuria and Mammalian Target of Rapamycin Inhibitors in Renal Transplantation
- The Conjugated Antimetabolite 5-Fdu-Ecyd and Its Cellular and Molecular Effects on Platinum-Sensitive Vs
- (12) Patent Application Publication (10) Pub. No.: US 2002/0183239 A1 Gibbons, JR
- Studies on the Antiprostatic Action of Estracyt, a Nitrogen Mustard of Estradici1
- Pharmacological and Therapeutics Agents That Target DNA Replication by Yves Pommier M.D., Ph.D.1 and Robert B
- M-TOR Inhibitors in Kidney Transplantation: a Comprehensive
- Mechanisms of Action of Cancer Chemotherapeutic Agents: DNA-Interactive Alkylating Agents and Antitumour Platinum-Based Drugs
- Comprehensive Analysis of Chemotherapeutic Agents That Induce Infectious Neutropenia
- 3.1 Basic Principles of Chemotherapy
- Antineoplastic Agents for Cancer
- Autophagy-Dependent Metabolic Reprogramming Sensitizes TSC2-Deficient Cells to the Antimetabolite 6-Aminonicotinamide
- 2 Combinations of Antimetabolites and Ionizing Radiation
- Daunorubicin and Ara-C (Cytarabine) – for Acute Myeloid Leukaemia (AML)
- Antimetabolite Treatment for Pancreatic Cancer
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- Alimta, INN-Pemetrexed
- Anticancer Drugs
- Mapping the Perturbome Network of Cellular Perturbations
- Part II Drugs Acting on Enzyme (Antimetabolites)
- Anatomisch-Therapeutisch- Chemische Klassifikation Mit Tagesdosen Für Den Deutschen Arzneimittelmarkt Gemäß § 73 Abs
- The Antimetabolites
- This Thesis Comes Within Category D
- Methotrexate Tablets, Usp
- Pemetrexed: Class: • Antineoplastic Agent, Antimetabolite (Antifolate)
- Genotoxic Anti-Cancer Agents and Their Relationship to DNA Damage, Mitosis, and Checkpoint Adaptation in Proliferating Cancer Cells
- Antineoplastic Drugs